Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 variation of propofol with low-dose nalbuphine for intravenous anesthesia in hysteroscopic surgery
ChiCTR2100042342Phase 4Recruiting
- Sponsor
- Department of Anesthesiology, First Affiliated Hospital of Anhui Medical University
- Start
- Jan 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of propofol and nalbuphine (2 arms), sponsored by Department of Anesthesiology, First Affiliated Hospital of Anhui Medical University. Primary endpoints: dosage of propofol, dosage of nalbuphine and 2 more. Started Jan 2021; status: recruiting.
02
Drugs
propofolnalbuphine
Beyond the preview
Go deeper on ChiCTR2100042342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042342.